Neona
Seocho
About Neona
Develops new liver cancer treatment drugs with various RNA and RNA regulator control strategies that function in cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.5M
- Funding stage: Seed
- Last round: Seed (Dec 2023)
- Website: neornat.comko
- Phone: 636-88-01728
Industries & Categories
Health Care, Health Diagnostics, Oncology, Therapeutics
Canonical: https://fsome.com/organization/neona-35 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.